ALXN

Q: What is the price of Alexion Pharmaceuticals (ALXN) today?

The current price of Alexion Pharmaceuticals (ALXN) is $ 0.00, representing a 0% gain over the past year. The stock began the year trading around $ 0.00 and is currently priced at $ 0.00. You can follow the real-time price chart, review historical performance, and track broader market trends directly on the platform.

Q: When does Alexion Pharmaceuticals (ALXN) pay dividends?

Alexion Pharmaceuticals (ALXN) did not pay dividends over the past year.

Alexion Pharmaceuticals Inc.

This asset is no longer available for investment.

View all assets

Price

$ -

return (12m)

0.00%

p/e

58.89

p/bv

3.23

DIVIDEND YIELD

0.00%

ALXN price

Alexion Pharmaceuticals

If you had invested

exposure

years ago

7 days

30 days

6 months

YTD

1 year

5 years

10 years

15 years

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Return on Investment ALXN

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

0.00%

3 months

0.00%

1 year

0.00%

2 years

0.00%

5 years

0.00%

10 years

0.00%

Fundamentals ALXN

review the fundamentals of Alexion Pharmaceuticals shares

P/E

58.89

Sector: -1.82 Industry: 0.93

P/S (PSR)

6.41

Sector: 1.92 Industry: 2.48

P/BV

3.23

Sector: 2.08 Industry: 2.36

DIVIDEND YIELD (DY)

0.00%

Sector: - Industry: -

ROA

3.66%

Sector: -29.19% Industry: -26.23%

ROE

5.48%

Sector: -35.78% Industry: -35.46%

ROIC

19.10%

Sector: -439.90% Industry: -95.47%

NET MARGIN

10.89%

Sector: -30.57% Industry: -31.02%

GROSS MARGIN

90.94%

Sector: 44.60% Industry: 49.89%

OPERATING MARGIN

47.07%

Sector: -25.44% Industry: -27.53%

EV/EBITDA

43.19

Sector: -0.35 Industry: 0.75

EV/EBIT

65.39

Sector: -1.82 Industry: 0.01

PRICE-TO-ASSETS

2.15

Sector: 1.13 Industry: 1.30

BVPS

56.50

Sector: 3.75 Industry: 5.05

EPS

3.10

Sector: -0.94 Industry: -0.69

EQUITY-TO-ASSETS RATIO

0.67

Sector: 0.42 Industry: 0.46

LIABILITIES / ASSETS

0.33

Sector: 0.46 Industry: 0.51

CAGR REVENUE 5 YEARS

30.78%

Sector: - Industry: -

CAGR PROFIT 5 YEARS

1.40%

Sector: - Industry: -

FAIR VALUE OF Alexion Pharmaceuticals ACCORDING TO BENJAMIN GRAHAM

Graham's Fair Value

The Fair Value formula was created by Benjamin Graham to identify stocks with appreciation potential or that are being traded for less than they are worth. Graham was one of the greatest investors in history and Warren Buffett’s mentor.

Current price

$ 0.00

Fair Value

$ 0.00

Upside/Downside Return potential.

See Graham's ranking

Because it considers equity value in its calculation, this formula may not work well for technology companies.

This is not a buy/sell recommendation; the fair value calculation takes into account only the formula created by Benjamin Graham, published in the book The Intelligent Investor.

Fundamentals ALXN

DRAG THE FRAME TO SEE MORE DATA

Stock Comparison Tool

DRAG THE FRAME TO SEE MORE DATA

	p/e	p/bv	ROE	dy	market cap	net margin
LLY	37.67	30.52	81.02%	0.59%	$ 952.11 B	34.99%
ISRG	50.60	8.57	16.93%	0.00%	$ 150.75 B	28.15%
SNY	7.24	1.29	17.79%	4.99%	$ 108.11 B	14.75%
TMO	24.35	3.20	13.15%	0.39%	$ 166.76 B	15.15%
NVS	21.44	7.45	34.77%	2.04%	$ 290.19 B	23.92%
ABT	24.34	0.00	-%	2.78%	$ 152.79 B	13.91%
MDT	21.86	2.05	9.38%	3.61%	$ 100.84 B	13.00%
GSK	13.07	4.41	33.77%	3.44%	$ 102.50 B	17.79%
CVS	40.49	1.53	3.78%	2.85%	$ 118.72 B	0.72%
BSX	20.26	2.79	13.78%	0.00%	$ 72.22 B	17.29%
TMDX	13.63	4.74	34.80%	0.00%	$ 2.34 B	27.04%
HCA	12.99	-29.64	-228.14%	0.75%	$ 88.27 B	8.89%
IDXX	41.16	28.97	70.38%	0.00%	$ 45.08 B	24.63%
RMD	19.85	4.65	23.41%	1.12%	$ 30.17 B	27.44%
DHR	33.01	2.30	6.97%	0.79%	$ 121.78 B	14.89%
INMD	10.07	1.33	13.18%	0.00%	$ 877.59 M	23.27%
PHG	21.85	1.87	8.56%	3.42%	$ 24.68 B	5.50%
SYK	36.22	5.26	14.52%	1.09%	$ 120.87 B	13.21%
FMS	10.81	0.72	6.71%	3.64%	$ 11.90 B	4.89%

Stock vs Indice Comparison Tool

If you had invested

years ago

2 years

5 years

10 years

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

ALXN Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

no dividend paid in the period.

ABOUT Alexion Pharmaceuticals

Alexion Pharmaceuticals Inc.

Average Investor10 user rating

4.0 (1 people)

United States

34 years

Founded: 1992

1996

Time since IPO - 30 years

3.837

Employees

Alexion Pharmaceuticals Inc. (United States) is listed on the Nasdaq and has a market capitalization of $40.15 Billions, with shareholders equity totaling $12.43 Billions.

The company employs approximately 3.837 people and operates in the Health sector, within the Main Medications industry.

Over the past 12 months, Alexion Pharmaceuticals Inc. reported $6.26 Billions in revenue, generating net income of $681.80 Millions.

Key financial metrics include a P/E ratio of 58.89, a price-to-book (P/B) ratio of 3.23, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker ALXN.

Market cap

$ 40.15 Billions

Net worth

$ 12.43 Billions

$ 12,431,000,000.00

Assets

$ 18.65 Billions

$ 18,650,200,000.00

Total Shares Outstanding

220.00 Millions

220,000,000

Average Daily Trading Volume

$ 5.81 Millions

$ 5,809,888.66

Sector

Health

Industry

Main Medications

ALXN

ALXN revenue and profits

Financial Results ALXN

DRAG THE FRAME TO SEE MORE DATA

ALXN cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more stocks

CI - Cigna

$ 277.40 --10,06% (12M)

P/E

11.64

2.13%

ROE

15.39%

P/BV

1.79

ABT - Abbott

$ 85.60 --34,61% (12M)

P/E

24.34

2.78%

ROE

P/BV

0.00

BSX - Boston Scientific

$ 48.31 --54,10% (12M)

P/E

20.26

0.00%

ROE

13.78%

P/BV

2.79

BDXB - Becton Dickinson

$ - -0,00% (12M)

P/E

8.75

0.00%

ROE

6.12%

P/BV

0.54

HSIC - Henry Schein

$ 76.58 9,42% (12M)

P/E

22.30

0.00%

ROE

8.19%

P/BV

1.83

ISRG - Intuitive Surgical

$ 424.64 --23,12% (12M)

P/E

50.60

0.00%

ROE

16.93%

P/BV

8.57

COHR - Coherent

$ 361.47 377,95% (12M)

P/E

146.48

0.00%

ROE

4.26%

P/BV

6.23

PDCO - Patterson Companies

$ - -0,00% (12M)

P/E

19.87

2.49%

ROE

14.02%

P/BV

2.79